ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.76B
Enterprise Value 32.34B
Trailing P/E N/A
Forward P/E 1-16.92
PEG Ratio (5 yr expected) 1-0.59
Price/Sales (ttm)1,467.68
Price/Book (mrq)10.68
Enterprise Value/Revenue 31,243.55
Enterprise Value/EBITDA 6-17.17

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-7,290.26%

Management Effectiveness

Return on Assets (ttm)-34.76%
Return on Equity (ttm)-68.11%

Income Statement

Revenue (ttm)1.88M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-73.20%
Gross Profit (ttm)1.84M
EBITDA -136.26M
Net Income Avi to Common (ttm)-152.35M
Diluted EPS (ttm)-4.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)240.22M
Total Cash Per Share (mrq)5.78
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.61
Book Value Per Share (mrq)6.22

Cash Flow Statement

Operating Cash Flow (ttm)-116.94M
Levered Free Cash Flow (ttm)-68.39M

Trading Information

Stock Price History

Beta 0.88
52-Week Change 3167.76%
S&P500 52-Week Change 313.18%
52 Week High 370.50
52 Week Low 321.95
50-Day Moving Average 364.05
200-Day Moving Average 353.04

Share Statistics

Avg Vol (3 month) 3131.94k
Avg Vol (10 day) 3122.92k
Shares Outstanding 541.52M
Float 20.88M
% Held by Insiders 124.93%
% Held by Institutions 144.51%
Shares Short 3344.86k
Short Ratio 32.9
Short % of Float 30.00%
Shares Short (prior month) 3329.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A